86 related articles for article (PubMed ID: 12447700)
1. Weak linkage at 4p16 to predisposition for human neuroblastoma.
Perri P; Longo L; Cusano R; McConville CM; Rees SA; Devoto M; Conte M; Ferrara GB; Seri M; Romeo G; Tonini GP
Oncogene; 2002 Nov; 21(54):8356-60. PubMed ID: 12447700
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition to familial neuroblastoma: identification of two novel genomic regions at 2p and 12p.
Longo L; Panza E; Schena F; Seri M; Devoto M; Romeo G; Bini C; Pappalardo G; Tonini GP; Perri P
Hum Hered; 2007; 63(3-4):205-11. PubMed ID: 17317969
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.
Maris JM; Weiss MJ; Mosse Y; Hii G; Guo C; White PS; Hogarty MD; Mirensky T; Brodeur GM; Rebbeck TR; Urbanek M; Shusterman S
Cancer Res; 2002 Nov; 62(22):6651-8. PubMed ID: 12438263
[TBL] [Abstract][Full Text] [Related]
4. Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig.
Bauer A; Savelyeva L; Claas A; Praml C; Berthold F; Schwab M
Genes Chromosomes Cancer; 2001 Jul; 31(3):228-39. PubMed ID: 11391793
[TBL] [Abstract][Full Text] [Related]
5. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
[TBL] [Abstract][Full Text] [Related]
6. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.
Ejeskär K; Sjöberg RM; Abel F; Kogner P; Ambros PF; Martinsson T
Med Pediatr Oncol; 2001 Jan; 36(1):61-6. PubMed ID: 11464908
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
Maris JM; Guo C; Blake D; White PS; Hogarty MD; Thompson PM; Rajalingam V; Gerbing R; Stram DO; Matthay KK; Seeger RC; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):32-6. PubMed ID: 11464900
[TBL] [Abstract][Full Text] [Related]
8. Detailed molecular analysis of 1p36 in neuroblastoma.
White PS; Thompson PM; Seifried BA; Sulman EP; Jensen SJ; Guo C; Maris JM; Hogarty MD; Allen C; Biegel JA; Matise TC; Gregory SG; Reynolds CP; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):37-41. PubMed ID: 11464901
[TBL] [Abstract][Full Text] [Related]
9. Peculiar allelotype associated with susceptibility to neuroblastoma.
Perri P; Pession A; Mazzocco K; Strigini P; Iolascon A; Basso G; Tonini GP
Genes Chromosomes Cancer; 1996 Sep; 17(1):60-3. PubMed ID: 8889508
[TBL] [Abstract][Full Text] [Related]
10. Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval.
Walker GJ; Indsto JO; Sood R; Faruque MU; Hu P; Pollock PM; Duray P; Holland EA; Brown K; Kefford RF; Trent JM; Mann GJ; Hayward NK
Genes Chromosomes Cancer; 2004 Sep; 41(1):56-64. PubMed ID: 15236317
[TBL] [Abstract][Full Text] [Related]
11. Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss.
Hoshi M; Otagiri N; Shiwaku HO; Asakawa S; Shimizu N; Kaneko Y; Ohi R; Hayashi Y; Horii A
Br J Cancer; 2000 Jun; 82(11):1801-7. PubMed ID: 10839294
[TBL] [Abstract][Full Text] [Related]
12. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
13. Familial predisposition to neuroblastoma does not map to chromosome band 1p36.
Maris JM; Kyemba SM; Rebbeck TR; White PS; Sulman EP; Jensen SJ; Allen C; Biegel JA; Yanofsky RA; Feldman GL; Brodeur GM
Cancer Res; 1996 Aug; 56(15):3421-5. PubMed ID: 8758905
[TBL] [Abstract][Full Text] [Related]
14. Oligogenic inheritance in neuroblastoma.
Longo L; Tonini GP; Ceccherini I; Perri P
Cancer Lett; 2005 Oct; 228(1-2):65-9. PubMed ID: 15923081
[TBL] [Abstract][Full Text] [Related]
15. Multilocus loss of heterozygosity allelotypes identify a genetic pathway associated with progression from low to high stage disease in neuroblastoma.
Chughtai SA; Genus T; Ramani P; Dyer S; Powell JE; McMullan D; Davison V; McConville CM;
Eur J Cancer; 2006 Aug; 42(12):1826-34. PubMed ID: 16872824
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a susceptibility locus for SLE, SLEB5, on chromosome 4p14-13.
Johansson CM; Kristjánsdottir H; Gröndal G; Steinsson K; Alarcón-Riquelme ME
Scand J Immunol; 2006 Sep; 64(3):308-13. PubMed ID: 16918700
[TBL] [Abstract][Full Text] [Related]
17. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Clin Cancer Res; 2003 Jan; 9(1):52-8. PubMed ID: 12538451
[TBL] [Abstract][Full Text] [Related]
18. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
White PS; Thompson PM; Gotoh T; Okawa ER; Igarashi J; Kok M; Winter C; Gregory SG; Hogarty MD; Maris JM; Brodeur GM
Oncogene; 2005 Apr; 24(16):2684-94. PubMed ID: 15829979
[TBL] [Abstract][Full Text] [Related]
19. Finer linkage mapping of primary osteoarthritis susceptibility loci on chromosomes 4 and 16 in families with affected women.
Forster T; Chapman K; Marcelline L; Mustafa Z; Southam L; Loughlin J
Arthritis Rheum; 2004 Jan; 50(1):98-102. PubMed ID: 14730605
[TBL] [Abstract][Full Text] [Related]
20. Refinement of 2q and 7p loci in a large multiplex NTD family.
Stamm DS; Siegel DG; Mehltretter L; Connelly JJ; Trott A; Ellis N; Zismann V; Stephan DA; George TM; Vekemans M; Ashley-Koch A; Gilbert JR; Gregory SG; Speer MC;
Birth Defects Res A Clin Mol Teratol; 2008 Jun; 82(6):441-52. PubMed ID: 18452155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
